• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
27.4543251
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
11.25
34.76
EPS(TTM)
Face Value()
Div & Yield %
3.6
10
0
 

Balaxi Pharmaceuticals consolidated net profit declines 92.94% in the March 2026 quarter
May 29,2026
Net profit of Balaxi Pharmaceuticals declined 92.94% to Rs 0.61 crore in the quarter ended March 2026 as against Rs 8.64 crore during the previous quarter ended March 2025. Sales declined 7.29% to Rs 70.71 crore in the quarter ended March 2026 as against Rs 76.27 crore during the previous quarter ended March 2025.

For the full year,net profit declined 94.34% to Rs 1.42 crore in the year ended March 2026 as against Rs 25.07 crore during the previous year ended March 2025. Sales declined 7.65% to Rs 270.17 crore in the year ended March 2026 as against Rs 292.56 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales70.7176.27 -7 270.17292.56 -8
OPM %0.1716.45 -3.1612.72 -
PBDT2.0510.12 -80 7.4530.56 -76
PBT1.409.66 -86 5.2928.67 -82
NP0.618.64 -93 1.4225.07 -94